Correction: A Signaling Network for Patterning of Neuronal Connectivity in the Drosophila Brain

por Srahna, Mohammed, Leyssen, Maarten, Choi, Ching Man, Fradkin, Lee, Noordermeer, Jasprina, Hassan, Bassem
Publicado 2006

A Signaling Network for Patterning of Neuronal Connectivity in the Drosophila Brain

por Srahna, Mohammed, Leyssen, Maarten, Choi, Ching Man, Fradkin, Lee G, Noordermeer, Jasprina N, Hassan, Bassem A
Publicado 2006

Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen

por Bockstal, Viki, Gaddah, Auguste, Goldstein, Neil, Shukarev, Georgi, Bart, Stephan, Luhn, Kerstin, Robinson, Cynthia, Anumendem, Dickson, Leyssen, Maarten, Douoguih, Macaya
Publicado 2021

Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study

por Van Damme, Pierre, Moiseeva, Anna, Marichev, Igor, Kervyn, Anne-Diane, Booy, Robert, Kuriyakose, Sherine, Brockway, Andrew, Ng, Su-Peing, Leyssen, Maarten, Jacquet, Jeanne-Marie
Publicado 2010

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant

por Langley, Joanne M., Aggarwal, Naresh, Toma, Azhar, Halperin, Scott A., McNeil, Shelly A., Fissette, Laurence, Dewé, Walthere, Leyssen, Maarten, Toussaint, Jean-François, Dieussaert, Ilse
Publicado 2017

Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment()

por Custers, Jerome, Kim, Denny, Leyssen, Maarten, Gurwith, Marc, Tomaka, Frank, Robertson, James, Heijnen, Esther, Condit, Richard, Shukarev, Georgi, Heerwegh, Dirk, van Heesbeen, Roy, Schuitemaker, Hanneke, Douoguih, Macaya, Evans, Eric, Smith, Emily R., Chen, Robert T.
Publicado 2021

Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 ope...

por Karita, Etienne, Nyombayire, Julien, Ingabire, Rosine, Mazzei, Amelia, Sharkey, Tyronza, Mukamuyango, Jeannine, Allen, Susan, Tichacek, Amanda, Parker, Rachel, Priddy, Frances, Sayinzoga, Felix, Nsanzimana, Sabin, Robinson, Cynthia, Katwere, Michael, Anumendem, Dickson, Leyssen, Maarten, Schaefer, Malinda, Wall, Kristin M.
Publicado 2022

Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola

por Bockstal, Viki, Leyssen, Maarten, Heerwegh, Dirk, Spiessens, Bart, Robinson, Cynthia, Stoop, Jeroen N., Roozendaal, Ramon, Van Effelterre, Thierry, Gaddah, Auguste, Van Roey, Griet A., Solforosi, Laura, Zahn, Roland, Callendret, Benoit, Hendriks, Jenny, Luhn, Kerstin, Douoguih, Macaya, Schuitemaker, Hanneke, Van Hoof, Johan
Publicado 2022

Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo

por Watson-Jones, Deborah, Kavunga-Membo, Hugo, Grais, Rebecca F, Ahuka, Steve, Roberts, Natalie, Edmunds, W John, Choi, Edward M, Roberts, Chrissy H, Edwards, Tansy, Camacho, Anton, Lees, Shelley, Leyssen, Maarten, Spiessens, Bart, Luhn, Kerstin, Douoguih, Macaya, Hatchett, Richard, Bausch, Daniel G, Muyembe, Jean-Jacques
Publicado 2022

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical tr...

por Barry, Houreratou, Mutua, Gaudensia, Kibuuka, Hannah, Anywaine, Zacchaeus, Sirima, Sodiomon B., Meda, Nicolas, Anzala, Omu, Eholie, Serge, Bétard, Christine, Richert, Laura, Lacabaratz, Christine, McElrath, M. Juliana, De Rosa, Stephen, Cohen, Kristen W., Shukarev, Georgi, Robinson, Cynthia, Gaddah, Auguste, Heerwegh, Dirk, Bockstal, Viki, Luhn, Kerstin, Leyssen, Maarten, Douoguih, Macaya, Thiébaut, Rodolphe
Publicado 2021

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phas...

por Anywaine, Zacchaeus, Barry, Houreratou, Anzala, Omu, Mutua, Gaudensia, Sirima, Sodiomon B., Eholie, Serge, Kibuuka, Hannah, Bétard, Christine, Richert, Laura, Lacabaratz, Christine, McElrath, M. Juliana, De Rosa, Stephen C., Cohen, Kristen W., Shukarev, Georgi, Katwere, Michael, Robinson, Cynthia, Gaddah, Auguste, Heerwegh, Dirk, Bockstal, Viki, Luhn, Kerstin, Leyssen, Maarten, Thiébaut, Rodolphe, Douoguih, Macaya
Publicado 2022

Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate

por Roozendaal, Ramon, Hendriks, Jenny, van Effelterre, Thierry, Spiessens, Bart, Dekking, Liesbeth, Solforosi, Laura, Czapska-Casey, Dominika, Bockstal, Viki, Stoop, Jeroen, Splinter, Daniel, Janssen, Sarah, Baelen, Ben van, Verbruggen, Nadia, Serroyen, Jan, Dekeyster, Eline, Volkmann, Ariane, Wollmann, Yvonne, Carrion, Ricardo, Giavedoni, Luis D., Robinson, Cynthia, Leyssen, Maarten, Douoguih, Macaya, Luhn, Kerstin, Pau, Maria Grazia, Sadoff, Jerry, Vandebosch, An, Schuitemaker, Hanneke, Zahn, Roland, Callendret, Benoit
Publicado 2020

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

por Afolabi, Muhammed O, Ishola, David, Manno, Daniela, Keshinro, Babajide, Bockstal, Viki, Rogers, Baimba, Owusu-Kyei, Kwabena, Serry-Bangura, Alimamy, Swaray, Ibrahim, Lowe, Brett, Kowuor, Dickens, Baiden, Frank, Mooney, Thomas, Smout, Elizabeth, Köhn, Brian, Otieno, Godfrey T, Jusu, Morrison, Foster, Julie, Samai, Mohamed, Deen, Gibrilla Fadlu, Larson, Heidi, Lees, Shelley, Goldstein, Neil, Gallagher, Katherine E, Gaddah, Auguste, Heerwegh, Dirk, Callendret, Benoit, Luhn, Kerstin, Robinson, Cynthia, Greenwood, Brian, Leyssen, Maarten, Douoguih, Macaya, Leigh, Bailah, Watson-Jones, Deborah
Publicado 2022

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised s...

por Ishola, David, Manno, Daniela, Afolabi, Muhammed O, Keshinro, Babajide, Bockstal, Viki, Rogers, Baimba, Owusu-Kyei, Kwabena, Serry-Bangura, Alimamy, Swaray, Ibrahim, Lowe, Brett, Kowuor, Dickens, Baiden, Frank, Mooney, Thomas, Smout, Elizabeth, Köhn, Brian, Otieno, Godfrey T, Jusu, Morrison, Foster, Julie, Samai, Mohamed, Deen, Gibrilla Fadlu, Larson, Heidi, Lees, Shelley, Goldstein, Neil, Gallagher, Katherine E, Gaddah, Auguste, Heerwegh, Dirk, Callendret, Benoit, Luhn, Kerstin, Robinson, Cynthia, Leyssen, Maarten, Greenwood, Brian, Douoguih, Macaya, Leigh, Bailah, Watson-Jones, Deborah
Publicado 2022